DONATE

Àngels López

Predoctoral Positions at IBEC within “la Caixa” Doctoral Fellowships INPhINIT

IBEC aims to train the next generation of researchers in bioengineering for future medicine, active ageing, and regenerative therapies. Thanks to IBEC’s interdisciplinarity, the most recent technical and technological approaches developed for research in the biomedical sciences are available. Young researchers can acquire experience and practical training day-to-day in imaging techniques, nanomaterials technology, stem cells, … Read more

Elisabeth Engel en radio Euskadi

On the occasion of the annual meeting of the centres of excellence “Severo Ochoa and Maria de Maeztu” (SOMMa) at the 100xCiencia event, held in San Sebastián on November 22 and 23, Elisabeth Engel spoke on radio Euskadi about the intelligent devices they are developing in their laboratory. These bandages release nanoparticles containing calcium ions that are able to heal chronic lesions such as ulcers.

Joan Montero and colleagues in Boston suggest a new strategy for melanoma patients

IBEC researcher Joan Montero authors a paper in Nature Communications which uncovers a key adaptation that melanoma cancer cells use to evade current therapies. This finding might allow physicians to use better drug combinations to improve patient outcomes in the future.

Despite significant advances in cancer diagnosis and treatment, most targeted cancer therapies fail to achieve complete tumor regressions or durable remission. Understanding why these treatments are not always efficient has remained a main challenge for researchers and physicians. Now, Joan Montero from the IBEC and colleagues at Dana-Farber Cancer Institute/Harvard Medical School in USA report in Nature Communications a mechanism that uncovers why some therapies fail to treat melanoma.

IBEC receives the FEI award for its support to innovation

Yesterday, the Innovative Companies Forum (“FEI”, in Spanish) celebrated the seventh edition of the 2019 “Innovation Awards”. The awards ceremony, which aims to highlight the commitment to innovation of organizations, companies and researchers, recognized the Institute for Bioengineering of Catalonia’s (or “IBEC”) “Innovation Support Agency”. David Badia, executive director of the institute, received the award during the ceremony, which took place in Madrid.

During his acceptance speech, Badia noted that IBEC is accredited as a Severo Ochoa Centre of Excellence and is dedicated to the field of bioengineering, with the objective not only to study, but to also promote the research’s application in the field of medicine, health and the improvement of people’s quality of life.

New advances in the treatment of advanced lung cancer

A research team led by Jordi Alcaraz, tenure track-2 lecturer from the Department of Biomedicine of the Faculty of Medicine and Health Sciences of the University of Barcelona and research associated at the Institute for Bioengineering of Catalonia (IBEC), in collaboration with the Hospital Clínic de Barcelona and the Boehringer Ingelheim company, has identified the molecular mechanisms than could have implications in the design of new therapeutic strategies to expand the clinical benefits of a drug to a larger spectra of patients with lung cancer.

IBEC launches its Clinical Colloquia Program

As a part of IBEC’s strategy to facilitate the transfer of excellent science into health solutions for patients and hospitals, the Institute fosters relations and partnerships with clinicians and companies. Within this framework, the Institute of Bioengineering of Catalonia has now launched the IBEC Clinical Colloquia Program.

Thanks to the nature of the research developed in the institute, IBEC counts on an ongoing and committed relationship with hospitals, medical doctors and patients. As a result, the involved partners are able to develop joint research projects, and in other cases they are a source of information about the unmet needs in clinical practice. With the launching of this clinical colloquia IBEC wants to strengthen these collaborations and offer the opportunity to create a space for discussion between researchers and medical doctors.

IBEC counts on collaboration of medical doctors to provide input on the clinical aspects of its research, so that results are easily extended to clinical practice.

Postdoctoral researcher at the IMEM Research Group


Application Deadline: 10/12/2019
Ref: PD-CA

The IMEM Group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Postdoctoral Researcher with broad experience in (Bio)Materials, Nanotechnology and Polymers/Biopolymers to develop a project on the development of (bio)polymeric materials for biomedical applications. The contract will be within the framework of IMEM-BRT research lines, whose objective is the development of new materials for regenerative therapies.
Specifically, the project involves the study of hydrogels as versatile platforms for specific (bio)applications using new chemistries, cell-friendly polymers (biopolymers and degradable synthetic polymers) and advanced manufacturing technologies. The research will involve three different areas that derive from the function, features, and source of hydrogels and, consequently, will require a wide range of skills (as per below).

Senior Posdoctoral Researcher at the Biosensors for bioengineering Group


Application Deadline: 20/12/2019
Ref: SPD-JR

The Biosensors for Bioengineering group led by Dr. Javier Ramón at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Posdoctoral Researcher in order to work in the project BENCHTOP NMR FOR LAB-ON-CHIP (BLOC), FET open. This position will be funded by H2020 European Union programme